Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Verma, Savita
NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers	Active, not recruiting	3	25800	RoW	BBV152, Placebo	Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd	Covid19, SARS-CoV Infection	01/21	12/22
Hillchol131, NCT05732766: To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)	Recruiting	3	1800	RoW	Hillchol vaccine	Bharat Biotech International Limited	Cholera	03/23	08/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Verma, Savita
NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers	Active, not recruiting	3	25800	RoW	BBV152, Placebo	Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd	Covid19, SARS-CoV Infection	01/21	12/22
Hillchol131, NCT05732766: To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)	Recruiting	3	1800	RoW	Hillchol vaccine	Bharat Biotech International Limited	Cholera	03/23	08/23